Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis

被引：0
|
作者：
Hauser, Stephen L. [1 ]
Kappos, Ludwig [2 ]
Montalban, Xavier [3 ,4 ]
Craveiro, Licinio [5 ]
Hughes, Richard [5 ]
Prajapati, Kalpesh [6 ]
Koendgen, Harold [5 ]
Pradhan, Ashish [7 ]
Wolinsky, Jerry S. [8 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Basel, Univ Hosp Basel, Basel, Switzerland
[3] Univ Toronto, Div Neurol, Toronto, ON, Canada
[4] Vall dHebron Univ Hosp, Barcelona, Spain
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] GCE Solut Inc, Bloomington, IL USA
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Houston, TX USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1147
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY
    Hauser, Stephen L.
    Belachew, Shibeshih
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1694 - 1694
  • [22] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Hartung, H. -P.
    Arnold, D. L.
    Bar-Or, A.
    Comi, G.
    de Seze, J.
    Giovannoni, G.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 658 - 659
  • [23] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Rammohan, Kottil W.
    Hartung, Hans-Peter
    Arnold, Douglas L.
    Bar-Or, Amit
    Comi, Giancarlo
    de Seze, Jerome
    Giovannoni, Gavin
    Hauser, Stephen L.
    Hemmer, Bernhard
    Kappos, Ludwig
    Lublin, Fred
    Montalban, Xavier
    Selmaj, Krzysztof
    Traboulsee, Anthony
    Chin, Peter
    Li, Carrie
    Mairon, Nicole
    Napieralski, Julie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 31 - 32
  • [24] UPDATED SAFETY ANALYSIS OF OCRELIZUMAB IN MULTIPLE SCLEROSIS
    Young, Carolyn
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Hughes, Richard
    Koendgen, Harold
    McNamara, John
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
  • [25] Infusion-related reactions with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    De Seze, J.
    Arnold, D. L.
    Bar-Or, A.
    Giovannoni, G.
    Hartung, H. -P.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Wolinsky, J.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 351 - 352
  • [26] Effect of Ocrelizumab on Thalamic Atrophy in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Arnold, Douglas L.
    Sprenger, Till
    Bar-Or, Amit
    Wolinsky, Jerry S.
    Kappos, Ludwig
    Kolind, Shannon
    Manfrini, Marianna
    Magon, Stefano
    van Beek, Johan
    Koendgen, Harold
    Bernasconi, Corrado
    Gaetano, Laura
    Traboulsee, Anthony
    NEUROLOGY, 2020, 94 (15)
  • [27] Ocrelizumab for primary progressive multiple sclerosis
    Adler, Ai
    Knight, H.
    LANCET NEUROLOGY, 2019, 18 (09): : 816 - 817
  • [28] Ocrelizumab for primary progressive multiple sclerosis
    Montalban X
    Hauser SL
    Kappos L
    中华物理医学与康复杂志, 2017, (03) : 174 - 174
  • [29] Safety results for administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis
    Vollmer, T.
    Alvarez, E.
    Nair, K. V.
    Cohen, J.
    Boster, A.
    Katz, J.
    Pardo, G.
    Pei, J.
    Raut, P.
    Merchant, S.
    Bobbala, A.
    Pradhan, A.
    Moss, B.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 778 - 779
  • [30] Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis
    Vollmer, Timothy L.
    Cohen, Jeffrey A.
    Alvarez, Enrique
    Nair, Kavita, V
    Boster, Aaron
    Katz, Joshua
    Pardo, Gabriel
    Pei, Jinglan
    Raut, Pranil
    Merchant, Sharmin
    MacLean, Elizabeth
    Pradhan, Ashish
    Moss, Brandon
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
12345